Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-γ

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 4, 2001, Pages 560-566

  Inoue, Mayumi ^a   Itoh, Hiroshi ^a   Tanaka, Tokuji ^a   Chun, Tae Hwa ^a   Doi, Kentaro ^a   Fukunaga, Yasutomo ^a   Sawada, Naoki ^a   Yamshita, Jun ^a   Masatsugu, Ken ^a   Saito, Takatoshi ^a   Sakaguchi, Satsuki ^a   Sone, Masakatsu ^a   Yamahara, Ken Ichi ^a   Yurugi, Takami ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Endothelial cells; Macrophages; Peroxisome proliferator activated receptor ; Vascular endothelial growth factors

Indexed keywords

13 HYDROXY 10,12 OCTADECADIENOIC ACID; DIMORPHECOLIC ACID; HYDROXY FATTY ACID; LIGAND; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN J2; TROGLITAZONE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADIPOCYTE; ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MACROPHAGE; MACROPHAGE MIGRATION; MONOCYTE; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SMOOTH MUSCLE FIBER;

EID: 0035049227     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.4.560     Document Type: Article

References (42)

1. Molecular and biological properties of the vascular endothelial growth factor family of proteins
2. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes
3. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
4. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries
5. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis
6. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions
7. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries
8. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis
9. Oxidative modification of LDL and atherogenesis
10. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoproteins
11. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia
12. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins
13. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins
14. Lipoproteins regulate C-type natriuretic peptide secretion from cultured vascular endothelial cells
15. The nuclear receptor superfamily: The second decade
16. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
17. 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
18. Adipogenesis and obesity: Rounding out the big picture
19. Characterization of new oral antidiabetic agent CS-045: Studies in KK and ob/ob mice and Zucker fatty rats
20. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone
21. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
22. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
23. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma
24. PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease
25. 2+-catalyzed oxidation of human low density lipoprotein
26. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors
27. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
28. Efficient selection for high-expression transfections with a novel eukaryotic vector
29. Thiazolidinediones and insulin resistance: Peroxisome proliferator-activated receptor gamma activation stimulates expression of the CAP gene
30. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma
31. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
32. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells
33. Activation of PPARgamma inhibits macrophage proliferation and migration: Possible therapeutic effectiveness of thiazolidinediones on diabetic vascular complications
34. Hypertension and insulin resistance: Role of peroxisome proliferator-activated receptor gamma
35. The CBP co-activator is a histone acetyl-transferase
36. Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor
37. PPARg agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression
38. Expression of vascular endothelial growth factor (VEGF) in human coronary atherosclerosis and its gene regulation by oxidized LDL (Ox-LDL): VEGF as a possible progression factor for human atherosclerosis
39. Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (hemagglutinating virus of Japan) liposomes: An effective tool for the in vivo study of arterial diseases
40. Atherosclerosis and angiogenesis: Its pathophysiological significance in humans as well as in an animal model induced by gene transfer of vascular endothelial growth factor (VEGF)
41. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: A prominent role for neovascularization?
42. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: Balance between growth and death signals